Antibodies specific for vascular endothelial growth factor-B
US6331301A · kind A · utility
19Cited by
5References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 6, 1997 |
| Grant date | Dec 18, 2001 |
| Priority date | — |
| Expiry date | May 6, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.